viewMMJ Group Holdings Ltd

MMJ Group makes additional C$2.5 million investment in Sequoya Cannabis

The company secured the additional investment opportunity by exercising a right to invest further in Sequoya to finance the company’s business plan.

MMJ Group Holdings Ltd - MMJ Group Holdings makes additional CAD$2.5 million investment in Sequoya Cannabis Ltd
Sequoya is now able to progress to the next step in becoming a major EU GMP-certified hemp CBD supplier

MMJ Group Holdings Ltd (ASX:MMJ) has agreed to provide a C$2.5 million secured convertible note facility to its investment Sequoya Cannabis Ltd which may be drawn in trenches.

The company advanced an initial C$350,00 on April 16 to Sequoya under this convertible note facility.

Following receipt of the initial advance, Sequoya’s Polish subsidiary, Sequoya Europe, is expected to begin production of CBD extracts and isolate in April 2020 at its European Union (EU) GMP Certified production facility.

MMJ secured this additional investment opportunity by exercising a right to invest up to a further C$2.5 million in Sequoya to finance the company’s business plan.

The initial advance was funded from the proceeds of the MMJ share purchase plan (SPP) completed on March 24.

Towards GMP-certified hemp CBD supplier

The Sequoya facility is built from the ground up with the strictest production, quality and safety standards, allowing quick and smooth certification of the entire facility.

It marks the only completely end-to-end EU GMP Certified hemp extraction facility in Europe.

As an end-to-end facility, it includes a modern, fully equipped analysis and quality control area, staffed with senior R&D and quality specialists ensuring tight control over producing consistent and highest quality results.

With few regulatory hurdles around CBD in Europe, Sequoya is receiving interest from consumer goods manufacturers namely from cosmetics, food, beverage and nutraceutical companies.

Following the financial backing of MMJ, Sequoya is now able to move to the next step to become a significant GMP-certified hemp CBD supplier, with longer-term plans to expand into the legal medicinal marijuana market across Europe.

‘Excellent’ investment returns

MMJ expects its investment in Sequoya to provide ‘excellent’ investment returns:

  • Sequoya is focusing on extraction, which is the highest value opportunity within the cannabis ecosystem, and has built a large-scale production plant in a low-cost jurisdiction which has easy no-tariff access to high-value markets such as Germany and Northern Europe;
  • As the industry evolves, the ability to produce GMP certified product at a lower cost in Europe will be a strategic advantage for Sequoya; and
  • Poland also provides access to world-class technicians and engineers at a substantially lower cost than available elsewhere, some of whom are already working with Sequoya.

Quick facts: MMJ Group Holdings Ltd

Price: 0.096 AUD

Market: ASX
Market Cap: $22.08 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...



Full interview: MMJ Group sees strong future for cannabis sector amid global...

MMJ Group (ASX: MMJ) Non-Executive Director Michael Curtis joined Steve Darling from Proactive Vancouver to discuss his thoughts on the cannabis industry and how that sector is doing during the Corona outbreak. Cannabis stores were deemed an essential service. Curtis also talked about how...

on 13/5/20

2 min read